Re: Ebola Update
Mysteries abound.
George Soros, his Ebola bioweapons lab and the death of WHO spokesperson Glenn Thomas (MH17 plane crash in the Ukraine)
_http://birdflu666.wordpress.com/2014/07/25/george-soros-ebola-and-the-death-of-who-spokesperson-glenn-thomas-in-the-ukraine/
Friday, July 25th, 2014
Some dots for you to connect:
*George Soros’s foundation funds the Kenema bioweapons lab at the focus of the Ebola outbreak, and which is about to be closed, apparently amid an investigation.
* WHO media coordinator Glenn Thomas was highly likely involved in fielding media and other inquries about how WHO view and what it planned to do about the controversial Kenema lab.
Was Glenn Thomas aware of hard evidence showing that the lab was faking positive diagnoses for Ebola — Tulane University? — in order to justify forcing people to undergo treatment which would give them Ebola? Did he refuse to go along with the cover up?
*The mainstream media is silent about the Kenema bioweapons lab closure as well as about the order to Tulane University to stop Ebola testing. So, what other channels are there left for this information to enter the public domain or be spread through social media networks if WHO does not release the information or take action?
*George Soros has links to Sierra Leone President Ernest Koroma
http://blogs.reuters.com/globalinvesting/tag/emerging-emerging-markets-frontier-markets-sierra-leone-africa-investment-george-soros-ernest-bai-koroma-tony-blair-anadarko/
*Soros also has links to the non-elected, far right, banker-controlled Ukrainian government, implicated in MH17 crash killing Glenn Thomas
http://www.infowars.com/soros-admits-responsibility-for-coup-and-mass-murder-in-ukraine/
*The Ukraine government shot down MH17, argues German blogge fefe.
Fefe’s argument: BUK missile launchers use radar and their signals can be tracked by NATO.
If NATO is suppressing the missile radar coordinates, then it is because the BUK missiles were launched by the Ukrainian government.
http://www.mmnews.de/index.php/politik/19212-mh17-fefe-ukraine-wars
*Soros attended the wedding of Dutch prince Johan Friso who married an employee of Soros in 2004
http://www.smh.com.au/articles/2004/04/24/1082719675482.html
http://www.washingtonpost.com/world/europe/johan-friso-dutch-prince-touched-by-scandal-dies-at-44/2013/08/14/96cae1fe-04fc-11e3-9259-e2aafe5a5f84_story.html
*The Dutch government flew back 40 bodies of the MH17 victims, call for a war crimes probe
http://www.timeslive.co.za/thetimes/2014/07/22/mh17-war-crime-probe
The Durch Prime Minister said another 200 bodies were being transported by train. But there were only 188 passengers on the MH17 according to Malayasian airlines. Where are all these bodies coming from?
*The Ukrainian bankster-controlled prime minister resigned yesterday, as brawls swept parliament over plans to crack down on civil rights and escalate the conflict with the ethnic Russian eastern Ukrainian provinces
http://news.yahoo.com/two-ukrainian-parties-leave-parliament-coalition-trigger-election-101228504.html
*Soros’ Open Society Foundation and and investment funds are active in the “Ebola death triangle” of Sierra Leone, Liberia and Guinea
http://www.opensocietyfoundations.org/press-releases/new-partnership-jump-starts-development-sierra-leone-and-liberia
Connecting these dots, does it seem likely to you that billionaire Soros had
a) a motive for killing WHO spokesperson Glenn Thomas to stop the news spreading through official channels that the Ebola outbreak was orchestrated in a Soros-funded lab;
b) a motive for silencing him very soon;
c) the means of silencing him by staging a fake air crash in the Ukraine?
d) the support of the Bilderberg, global elite?
Interesting is the complete silence of the mainstream media on the closure of the Kenema lab posted on the Sierra Leone Ministery of Health facebook site.
If the media really were a free press, interested in investigating scandals in the public interest and in reporting facts as the so called “fourth estate”, this story about the Kenema lab closure would be front page news around the globe just as the story of Baxter contaminating 72 kilos of seasonal flu in its biosecurity level 3 lab and sending it to four countries in 2009 should have been front page news.
It is the total media blackout and silence which red flags the key, global stories. The key story of 21st century is that we have entered an era of biological warfare. The main warfare is not conducted between nations but between the elite and the people of the globe using also vaccines, weaponized viruses and mass deception.
The Secret Serum Given To Ebola Patients Is Genetically Modified Tobacco Plants
_http://survivalbackpack.us/secret-serum-given-ebola-patients-genetically-modified-tobacco-plants/
Monday August 4, 2014
The drug being credited with potentially saving the lives of two American missionaries infected with the deadly Ebola virus was produced at a facility in Owensboro.
The serum wasn’t manufactured but grown, in a greenhouse full of genetically modified tobacco plants.
Kentucky BioProcessing, which was acquired by Reynolds American in January, conducts contract research and development for San Diego-based Mapp Biopharmaceutical, said David Howard, spokesman for RAI Services, a subsidiary of Reynolds American.
“In the last week, Kentucky BioProcessing complied with a request from Emory University and Samaritan’s Purse to provide a very limited amount (of the compound) to Emory, and KPB has done that,” Howard said.
CNN and NBC News reported Monday that ZMapp had been given to Dr. Kent Brantly and Nancy Writebol, who have been described as showing significant improvement.
The experimental drug apparently had never been tested on humans before.
In 2007, Mapp, working under contract for the U.S. Department of Defense and other federal agencies, engaged KBP to develop a process to manufacture a compound designed to be a post-exposure treatment for Ebola virus.
That compound was MB-003 or ZMapp, a cocktail of antibodies that has proven to be the most effective so far in fighting off the Ebola virus.
In a study published last year, U.S. Army Medical Research Institute of Infectious Diseases scientists reported that 43 percent of infected non-human primates recovered after receiving the treatment intravenously 104 to 120 hours after infection — after symptoms developed.
“Mapp Biopharmaceutical has the structure of this protein to battle the Ebola. And KPB is building that protein,” Howard said. In Owensboro, tobacco plants are “infected” with the protein, he said, and then they reproduce it “like a photocopier.” The desired proteins are extracted from the plants and purified into a serum. Scientists have long known that tobacco readily picks up genes inserted into it. The Owensboro facility uses that ability to quickly and inexpensively produce large volumes of a compound in a matter of weeks. KBP also has been selected for work on some of the biggest health threats on the planet, including H1N1 vaccine production, an anti-rabies antibody, norovirus or the “cruise ship virus,” for HIV prevention, for parvovirus, and for HPV vaccine. ZMapp, the drug that was used on the American Ebola victims, has not been approved as a drug in the U.S. or in other countries, Howard said, but the Owensboro facility had begun ramping up production for anticipated drug approval testing protocols later this year. That process may now be accelerated. “KBP is working closely with Mapp and other agencies to increase production, but that process will take several months,” Howard said.
The Curious Recovering Americans and the 'Top Secret' Ebola Treatment
_http://www.economicpolicyjournal.com/2014/08/the-curious-recovering-americans-and.html
Monday, August 4, 2014
More developments that suggest the possibility that US biowarfare operators may be involved with Ebola research, and quite possibly the outbreak in Africa.
The Atlantic reports:
Ebola is notoriously incurable (and the strain at large its most lethal), it is overwhelming to hear that "Secret Serum Likely Saved Ebola Patients," as we do this morning from Gupta's every-20-minute CNN reports. He writes:
Three top secret, experimental vials stored at subzero temperatures were flown into Liberia last week in a last-ditch effort to save two American missionary workers [Drs. Kent Brantly and Nancy Writebol] who had contracted Ebola, according to a source familiar with details of the treatment.
Brantly had been working for the Christian aid organization Samaritan's Purse as medical director of the Ebola Consolidation Case Management Center in Monrovia, Liberia. The group yesterday confirmed that he received a dose of an experimental serum before leaving the country.
In Gupta's optimistic assessment, Brantly's "near complete recovery" began within hours of receiving the treatment that "likely saved his life." Writebol is also reportedly improved since receiving the treatment, known as zMapp. But to say that it was a secret implies a frigid American exceptionalism; that the people of West Africa are dying in droves while a classified cure lies in wait...
[T]he proprietary blend of three monoclonal antibodies known as zMapp had never been tested in humans. It had previously been tested in eight monkeys with Ebola who survived—though all received treatment within 48 hours of being infected. A monkey treated outside of that exposure window did not survive. That means very little is known about the safety and effectiveness of this treatment—so little that outside of extreme circumstances like this, it would not be legal to use. Gupta speculates that the FDA may have allowed it under the compassionate use exemption.
From the very sparse web site of the zMapp developer, Mapp Biopharmecutical:
ZMappTM is the result of a collaboration between Mapp Biopharmaceutical,Inc. and LeafBio (San Diego,CA), Defyrus Inc. (Toronto, Canada), the U.S. government and the Public Health Agency of Canada (PHAC).
Among its partners, LeafBio lists:
United States Army Medical Research Institute for Infectious Disease (USAMRIID) – Virology Division
and
Defence Research and Development Canada
From an August 2013 U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) report:
Scientists have successfully treated the deadly Ebola virus in infected animals following
onset of disease symptoms, according to a report published online today in Science Translational Medicine. The results show promise for developing therapies against the virus, which causes hemorrhagic fever with human case fatality rates as high as 90 percent.
According to first author James Pettitt of the U.S. Army Medical Research Institute of
Infectious Diseases (USAMRIID), the research team previously demonstrated that the
treatment—known as MB-003—protected 100 percent of non-human primates when given one hour after Ebola exposure. Two-thirds of the animals were protected when treated 48 hours after
exposure...
“By requiring both a documentable fever and a positive diagnostic assay result for Ebola
infection before initiating treatment in these animals, we were able to use MB-003 as a true
therapeutic countermeasure,” said senior author Gene Olinger, Ph.D., of USAMRIID. “These
initial results push the threshold of MB-003 from post-exposure prophylaxis to treating verified
illness.”...
USAMRIID’s mission is to protect the warfighter from biological threats and to be
prepared to investigate disease outbreaks or threats to public health. Research conducted at
USAMRIID leads to medical solutions—vaccines, drugs, diagnostics, and information—that
benefit both military personnel and civilians. The Institute plays a key role as the lead military
medical research laboratory for the Defense Threat Reduction Agency’s Joint Science and
Technology Office for Chemical and Biological Defense. USAMRIID is a subordinate
laboratory of the U.S. Army Medical Research and Materiel Command.
UPDATE:
The firm producing (part of?) zMapp is Kentucky Bioprocessing, LLC (KBP)
Hugh Haydon is the founding Chairman and CEO of KBP.
Prior to assuming his current role with KBP, Haydon served as Executive Vice-President of Programs for a Washington, DC based consulting group providing strategic and implementation direction to various research, development and commercialization programs for the United States Department for Homeland Security.
According to Kentucky.gov, since 2010 KBP has secured and successfully executed over $30 million in contracts with the United States Department of Defense "aimed at protecting the warfighter and general public from various biological threats."
In 1999, Haydon was presented with the Kentucky Distinguished Service Medal for his service in support of the Kentucky Commission on Military Affairs.
The big questions:
1. Was the U.S. military only doing research to find a treatment or were they attempting to also develop Ebola as a biowarfare weapon?
2. Were they conducting Ebola research in Africa, which appears to be the case? SEE: A Link Between the Ebola Outbreak and a US Bioweapons Lab?
3. Did they lose control of their research experiments in Africa which has resulted in the current Ebola outbreak?